Cullinan Therapeutics Inc CGEM Q1 2026 Earnings Beat on EPS with NarrowerThanExpected Loss HIMS Q1 2026 Earnings Significant EPS Miss as Loss Deepens Stock Declines GPMT Q1 2026 Earnings NarrowerThanExpected Loss Signals Potential Stabilization STRA Q1 2026 Earnings EPS Misses Estimates Stock Slides Slightly Deutsche Bank Q1 2026 Earnings Modest EPS Beat Amid Mixed Market Sentiment BFS Q1 2026 Earnings Massive EPS Beat Drives Positive Stock Reaction Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline Stepan Company SCL Q1 2026 Earnings EPS Slightly Tops Estimates Revenue Not Disclosed TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage AIP Q1 2026 Earnings Significant EPS Beat Highlights Operational Discipline VABK Q1 2026 Earnings EPS of 097 Highlights Steady Performance Amid Limited Disclosure CTGO Q1 2026 Earnings Significant EPS Miss Raises Concerns